Antecedentes Los fármacos con propiedades anticolinérgicas se prescriben habitualmente
a los adultos mayores con un diagnóstico preexistente de demencia o deterioro cognitivo. El …

Anticholinergic medication use bears an increased risk of dementia development, and
accelerated cognitive decline in individuals with preexisting dementia, with the risk being …

Objective To describe medicines regimens used by older people living in residential aged
care facilities (RACFs). Materials and methods This cross-sectional study presents baseline …

Introduction Studies have shown that use of medicines with sedative or anticholinergic
properties is associated with a decline in physical function; however, the effects have not …

Drug-induced movement disorders (DIMDs) are associated with use of dopamine receptor
blocking agents (DRBAs), including antipsychotics. The most common forms are drug …

Background Choline alfoscerate, a cholinergic precursor with limited evidence of efficacy in
dementia management, has been used for various cognitive impairments in Korea. Partly …

Objectives This review aims to comprehensively summarize the differences in
anticholinergic drug burden (ADB) scores between older hospitalized patients with and …

Background The purpose of this study was to investigate the relationship between
anticholinergic burden (ACB), and cognitive and functional alterations in patients with …

Introduction Older patients with dementia or mild cognitive impairment (MCI) are particularly
vulnerable to adverse effects from potentially inappropriate medications (PIMs). Previous …

This article provides a practical approach to identifying drugs that increase the
anticholinergic burden and recognise risks and adverse effects. Suggestion will be offered to …